Form 4 for MNPR Monopar Therapeutics
Accepted 2024-10-30 00:00:00 ET · period of report 2024-10-28 · accession 0001437749-24-032626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-30 | 2024-10-28 | MNPR | Radhakrishnan Karthik | CFO | P - Purchase | $16.25 | +1,550 | 1,550 | New | +$25.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-28 | P | A | 1,550 | $16.25 | 1,550 | D | — | — | (F1) The price reported in Column 4 is the Public offering price in the prospectus dated October 28, 2024. |